COVID-19 patients, particularly those with severe symptoms, are more susceptible to developing secondary bacterial infections due to weakened immune systems. Antibiotics are often used to treat these infections, but the overuse of antibiotics has led to the emergence of antibiotic-resistant bacterial strains. Streptococcus pneumoniae, Staphylococcus aureus, Haemophilus influenzae, Klebsiella pneumoniae, Acinetobacter baumannii, Escherichia coli, Pseudomonas aeruginosa, and Legionella pneumophila are some of the bacteria commonly associated with COVID-19. Post-COVID-19 bacterial pneumonia is a potential complication that may arise after a person has recovered from COVID-19. Post-COVID-19 antibiotic resistance is a growing concern in healthcare as a significant increase in resistance was found in the bacterial isolates to Amoxycillin, Cephalosporins, Carbapenems, Azithromycin, Clarithromycin, and Ciprofloxacin.